AAMU
MRNA icon

Amundi Asset Management US’s Moderna MRNA Stock Holding History

Amundi Asset Management US’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$62M Sell
473,216
-14,389
-3% -$2.09M 0.05% 366
2020
Q4 		$50.9M Buy
487,605
+12,575
+3% +$1.27M 0.04% 390
2020
Q3 		$33.6M Sell
475,030
-184,617
-28% -$12.9M 0.04% 422
2020
Q2 		$42.4M Buy
659,647
+319,502
+94% +$17.5M 0.05% 341
2020
Q1 		$10.2M Sell
340,145
-613,618
-64% -$14.1M 0.02% 556
2019
Q4 		$18.7M Buy
953,763
+65,436
+7% +$1.16M 0.02% 587
2019
Q3 		$14.1M Buy
888,327
+239,141
+37% +$3.53M 0.02% 620
2019
Q2 		$9.5M Sell
649,186
-89,962
-12% -$1.93M 0.01% 799
2019
Q1 		$15M Buy
+739,148
New +$13.7M 0.02% 603

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Amundi Asset Management US's MRNA Position: Q1 2021 in Review

Amundi Asset Management US reduced its Moderna (MRNA) stake by 3% in Q1 2021, selling an estimated $2.09M and leaving 473,216 shares worth $62M. The position accounts for 0.05% of the portfolio, ranked #366.

Amundi Asset Management US first reported a position in MRNA in Q1 2019 and has held it in 9 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

  • Amundi Asset Management US held 473,216 shares of Moderna worth $62M as of Q1 2021.
  • Amundi Asset Management US sold 14,389 Moderna shares in Q1 2021, an estimated $2.09M.
  • Moderna made up 0.05% of Amundi Asset Management US's portfolio in Q1 2021, its #366 holding.
  • Amundi Asset Management US first reported a position in Moderna in Q1 2019 and has held it in 9 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.